BIOMAT Database Logo BIOMAT Database Logo

[Agranulocytosis during levamisole treatment]. 1979

N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov

UI MeSH Term Description Entries
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
[Letter: Agranulocytosis during treatment with levamisole].
April 1976, La Nouvelle presse medicale,
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
[Case of agranulocytosis during treatment of rheumatoid arthritis with levamisole].
January 1979, Reumatologia,
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
Levamisole and agranulocytosis.
April 1977, Lancet (London, England),
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
Levamisole and agranulocytosis.
October 1976, Lancet (London, England),
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
[Letter: Agranulocytosis during rheumatoid arthritis treated by levamisole].
May 1976, La Nouvelle presse medicale,
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
[Unusually rapid development of agranulocytosis during treatment with low doses of levamisole].
January 1984, Terapevticheskii arkhiv,
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
[Agranulocytosis caused by levamisole].
January 1978, Orvosi hetilap,
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
Recurrent agranulocytosis after levamisole.
January 1977, Lancet (London, England),
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
Agranulocytosis due to levamisole.
December 1976, Lancet (London, England),
N V Bunchuk, and A P Burdeĭnyĭ, and A T Tananov
Letter: Levamisole and agranulocytosis.
May 1976, Lancet (London, England),
Copied contents to your clipboard!